What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-03-30 compared with 2025-04-09 · 52 added, 20 removed, 4 unchanged (95% of the section changed)

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

MARKET FOR REGISTRANT’S

COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Common Stock is currently listed on the NASDAQ Capital Market under the trading symbol “GRNQ.” Our Common Stock did not trade

prior to July 9, 2015.

April 8, 2025, the closing price for our Common Stock as reported on the NASDAQ Capital Market was $0.89.

of April 9, 2025, we had 7,575,813 shares of our Common Stock issued and outstanding.

There were approximately 190 record holders of

our Common Stock.

Such number does not include any shareholders holding shares in nominee or “street name”.

have not declared or paid dividends on our Common Stock since our formation, and we do not anticipate paying dividends in the foreseeable

Declaration or payment of dividends, if any, in the future, will be at the discretion of our board of directors and will depend

on our current financial condition, results of operations, capital requirements and other factors deemed relevant by the board of directors.

There are no contractual restrictions on our ability to declare or pay dividends.

Sales of Unregistered Securities

sales of unregistered Common Stock of the Company were made in reliance upon Section 4(a)(2) of the Securities Act, Regulation D and/or

Rule 903 of Regulation S promulgated thereunder.

2024 and 2023, the Company did not issue any shares of its Common Stock.

Compensation Plan Information

have not adopted or approved an equity compensation plan.

On March 27, 2026, the closing

price for our Common Stock as reported on the NASDAQ Capital Market was $2.72.

As of March 30, 2026, we had

8,625,813 shares of our Common Stock issued and outstanding.

There were approximately 195 record holders of our Common Stock.

does not include any shareholders holding shares in nominee or “street name”.

Dividend Policy

We have not declared or paid

dividends on our Common Stock since our formation, and we do not anticipate paying dividends in the foreseeable future.

Declaration or

payment of dividends, if any, in the future will be at the discretion of our board of directors and will depend on our current financial

condition, results of operations, capital requirements and other factors deemed relevant by the board of directors.

There are no contractual

restrictions on our ability to declare or pay dividends.

Recent Sales of Unregistered Securities

All sales of unregistered Common

Stock of the Company were made in reliance upon Section 4(a)(2) of the Securities Act, Regulation D and/or Rule 903 of Regulation S promulgated

During 2024, the Company did not

issue any shares of its Common Stock.

During 2025, the Company in aggregate

issued 1,050,000 shares of its Common Stock to individual investors in private placements, for total cash proceeds of $1,235,000.

proceeds aim to fund the expansion of the Company’s operations.

A list of the sales and issuance

of the Company’s Common Stock during 2025 is set forth below:

Name of Shareholder

Shares of Common

Cash Proceeds

from Share Issuance

Poon, Tsz Yu (1)

Tan, Lee Sha (1)

Chui, Sang Derek (1)

Ho, Tak Leung (1)

Good Girl Environmental Plant Research Center Limited (1), (2), (5)

Ngai, Suk Fun (3)

Lam, Hung Tak (3)

Yeung, Kam Shing William (3), (4)

Kwan, Tak Hing (3)

Tam, Kwai Ching (4)

Song, Shijie (4)

On June 10, 2025, the Company entered into subscription agreements with five (5) individual investors, providing for the private placement of an aggregate of 500,000 shares of the Company’s Common Stock, par value $0.0001, at a per share purchase price of $1.00 for cash proceeds of $500,000.

On June 23, 2025, the Company entered into a subscription agreement with one (1) individual investor, providing for the private placement of 200,000 shares of the Company’s Common Stock, par value $0.0001, at a per share purchase price of $1.30 for cash proceeds of $260,000.

On October 1, 2025, the Company entered into subscription agreements with four (4) individual investors, providing for the private placement of an aggregate of 100,000 shares of the Company’s Common Stock, par value $0.0001, at a per share purchase price of $1.30 for cash proceeds of $130,000.

On November 14, 2025, the Company entered into subscription agreements with three (3) individual investors, providing for the private placement of an aggregate of 150,000 shares of the Company’s Common Stock, par value $0.0001, at a per share purchase price of $1.30 for $195,000.

On December 18, 2025, the Company entered into subscription agreements with one (1) individual investor, providing for the private placement of an aggregate of 100,000 shares of the Company’s Common Stock, par value $0.0001, at a per share purchase price of $1.50 for cash proceeds of $150,000.

Equity Compensation Plan Information

not adopted or approved an equity compensation plan.

None of the options, warrants or other convertible securities, have been granted

outside of an approved equity compensation plan.

Agent and Registrar

transfer agent for our capital stock is VStock Transfer, LLC, whose business address is 18 Lafayette Place, Woodmere, NY 11598 and telephone

number is 212-828-8436.

of Common Stock

Transfer Agent and Registrar

agent for our capital stock is VStock Transfer, LLC, whose business address is 18 Lafayette Place, Woodmere, NY 11598 and telephone number

is 212-828-8436.

Repurchase of Common Stock

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity